The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
Healthequity Inc (NASDAQ: HQY) closed the day trading at $94.51 down -1.21% from the previous closing price of $95.67. In other words, the price has decreased by -$1.21 from its previous closing price. On the day, 0.7 million shares were traded. HQY stock price reached its highest trading level at $96.35 during the session, while it also had its lowest trading level at $93.91.
Ratios:
For a better understanding of HQY, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 26.11 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 19.55. For the most recent quarter (mrq), Quick Ratio is recorded 4.13 and its Current Ratio is at 4.13. In the meantime, Its Debt-to-Equity ratio is 0.48 whereas as Long-Term Debt/Eq ratio is at 0.48.
Upgrades & Downgrades
In the most recent recommendation for this company, BMO Capital Markets on November 13, 2025, initiated with a Market Perform rating and assigned the stock a target price of $100.
Raymond James Upgraded its Outperform to Strong Buy on March 25, 2025, whereas the target price for the stock was revised from $120 to $115.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Nov 20 ’25 when Ladd Delano sold 1,500 shares for $104.56 per share. The transaction valued at 156,840 led to the insider holds 75,479 shares of the business.
Ladd Delano sold 1,500 shares of HQY for $138,105 on Oct 20 ’25. The EVP, General Counsel now owns 76,979 shares after completing the transaction at $92.07 per share. On Oct 06 ’25, another insider, Delano Ladd, who serves as the Officer of the company, bought 977 shares for $88.57 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, HQY now has a Market Capitalization of 8172785664 and an Enterprise Value of 8793588736. As of this moment, Healthequity’s Price-to-Earnings (P/E) ratio for their current fiscal year is 43.31, and their Forward P/E ratio for the next fiscal year is 20.90. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 2.23. For the stock, the TTM Price-to-Sale (P/S) ratio is 6.26 while its Price-to-Book (P/B) ratio in mrq is 3.79. Its current Enterprise Value per Revenue stands at 6.813 whereas that against EBITDA is 19.345.
Stock Price History:
The Beta on a monthly basis for HQY is 0.20, which has changed by -0.06425744 over the last 52 weeks, in comparison to a change of 0.13506866 over the same period for the S&P500. Over the past 52 weeks, HQY has reached a high of $116.65, while it has fallen to a 52-week low of $74.07. The 50-Day Moving Average of the stock is -1.77%, while the 200-Day Moving Average is calculated to be -0.79%.
Shares Statistics:
Over the past 3-months, HQY traded about 884.95K shares per day on average, while over the past 10 days, HQY traded about 882270 shares per day. A total of 85.61M shares are outstanding, with a floating share count of 83.50M. Insiders hold about 2.26% of the company’s shares, while institutions hold 105.18% stake in the company. Shares short for HQY as of 1763078400 were 4007530 with a Short Ratio of 4.53, compared to 1760486400 on 4235174. Therefore, it implies a Short% of Shares Outstanding of 4007530 and a Short% of Float of 5.390000000000001.
Earnings Estimates
Its stock is currently analyzed by 13.0 different market analysts. The consensus estimate for the next quarter is $1.13, with high estimates of $1.22 and low estimates of $1.03.
Analysts are recommending an EPS of between $4.0 and $3.85 for the fiscal current year, implying an average EPS of $3.94. EPS for the following year is $4.53, with 12.0 analysts recommending between $4.74 and $4.27.
Revenue Estimates
15 analysts predict $332.23M in revenue for. The current quarter. It ranges from a high estimate of $339.21M to a low estimate of $327.89M. As of. The current estimate, Healthequity Inc’s year-ago sales were $311.82MFor the next quarter, 15 analysts are estimating revenue of $351.76M. There is a high estimate of $356.86M for the next quarter, whereas the lowest estimate is $345.1M.
A total of 15 analysts have provided revenue estimates for HQY’s current fiscal year. The highest revenue estimate was $1.32B, while the lowest revenue estimate was $1.3B, resulting in an average revenue estimate of $1.31B. In the same quarter a year ago, actual revenue was $1.2BBased on 14 analysts’ estimates, the company’s revenue will be $1.41B in the next fiscal year. The high estimate is $1.44B and the low estimate is $1.39B.
